Drugs News and Research

RSS

Research finding could set stage for potential development of new antimicrobial drugs

Research teams from the National Institutes of Health and abroad have identified the first inhibitor of an enzyme long thought to be a potential drug target for fighting disease-causing parasites and bacteria.

3 Apr 2017

Researchers develop new technologies to measure key proteins that serve as markers for tumors

Dr. Amanda Paulovich, whose lab has a leading role in the Beau Biden Cancer Moonshot, will speak April 5 at the American Association for Cancer Research annual meeting about her lab's pioneering methods to measure proteins that serve as tumor markers.

3 Apr 2017

Antibe Therapeutics grants options to purchase common shares

Antibe Therapeutics Inc. announces that it has granted its directors, officers and employees options to purchase a total of 9,496,000 common shares of Antibe pursuant to the Company's stock option plan.

3 Apr 2017

Higher free thyroxine levels may be linked to greater risk of atherosclerotic diseases

Middle-aged and elderly people with higher free thyroxine levels may be more likely to develop atherosclerotic diseases, new research from the Netherlands reports. The results of the study will be presented Sunday, April 2, at ENDO 2017, the annual meeting of the Endocrine Society, in Orlando, Fla.

3 Apr 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.

2 Apr 2017

BPS shows potential for increasing aggressiveness of breast cancer, study finds

Bisphenol S (BPS), a substitute for the chemical bisphenol A (BPA) in the plastic industry, shows the potential for increasing the aggressiveness of breast cancer through its behavior as an endocrine-disrupting chemical, a new study finds.

2 Apr 2017

Publicly-funded research key to improving biomedical innovation

A new paper co-authored by Columbia University Mailman School of Public Health's Bhaven Sampat, PhD, shows that 30 percent of all NIH-funded grants produce research that is cited by a private-sector patent.

31 Mar 2017

FDA alerts consumers to voluntary recall of Mylan's EpiPen and EpiPen Jr Auto-Injector products

The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies' voluntary recall of 13 lots of Mylan's EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions.

31 Mar 2017

ACR outlines health policy priorities to improve access to arthritis care and treatments

The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to care and treatments for the 54 million Americans living with arthritis and other rheumatologic diseases.

31 Mar 2017

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Bayer today announced positive data on its investigational compound copanlisib, an intravenous pan-Class I phosphatidylinositol-3-kinase (PI3K) inhibitor with predominant inhibitory activity against PI3K-α and PI3K-δ isoforms.

31 Mar 2017

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN N.V. today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer.

From QIAGEN Manchester Limited 31 Mar 2017

NIHR Innovation Observatory to aid future advances in healthcare

Future advances in healthcare will be aided by a new £10 million facility - the National Institute for Health Research Innovation Observatory.

31 Mar 2017

New smartwatch app helps men to boost sexual performance

Simply180, a full service marketing and advertising agency announced today the beta launch of "Fitdix", a new app it developed that uses smartwatch and artificial intelligence technology to help men end their reliance on pharmaceuticals to boost sexual performance and reduce premature ejaculation.

31 Mar 2017

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.

31 Mar 2017

New research to explore how socio-economic factors, other health concerns affect cancer treatment

How do health and socio-economic factors impact the nearly 1.7 million people diagnosed with cancer each year? RTI International plans to explore this through a new Robert Wood Johnson Foundation grant.

31 Mar 2017

Fighting colorectal cancer

Colorectal cancer is a combined term to describe the malignant tumors that occur in the large intestine; the colon being the upper part of the large intestine and the rectum being the lowest part of the large intestine.

31 Mar 2017

GHIT Fund invests in phase 3 clinical trial for pediatric formulation of ‘snail fever’ drug

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced 11 new investments totaling US$23 million that could help deliver a range of new innovative therapies for a host of debilitating conditions.

31 Mar 2017

Researchers develop biomaterials from apple waste for regeneration of bone, cartilage tissues

Researchers from UPM and CSIC have employed waste from the agri-food industry to develop biomaterials that are able to act as matrices to regenerate bone and cartilage tissues, which is of great interest for the treatment of diseases related to aging.

30 Mar 2017

Novel Research Grants bring new insight to complexities of lupus

The Lupus Research Alliance announced today the Novel Research Grant Class of 2017. The Lupus Research Alliance Novel Research Grants, the proven platform for innovation, make discovery and scientific progress possible.

30 Mar 2017

New imaging tool that spots lung infections could help prevent antibiotic overuse

A new imaging tool that rapidly diagnoses bacterial lung infections could help prevent unnecessary use of antibiotics in intensive care units.

30 Mar 2017

Drugs News and Research

Research finding could set stage for potential development of new antimicrobial drugs

Researchers develop new technologies to measure key proteins that serve as markers for tumors

Antibe Therapeutics grants options to purchase common shares

Higher free thyroxine levels may be linked to greater risk of atherosclerotic diseases

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

BPS shows potential for increasing aggressiveness of breast cancer, study finds

Publicly-funded research key to improving biomedical innovation

FDA alerts consumers to voluntary recall of Mylan's EpiPen and EpiPen Jr Auto-Injector products

ACR outlines health policy priorities to improve access to arthritis care and treatments

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

NIHR Innovation Observatory to aid future advances in healthcare

New smartwatch app helps men to boost sexual performance

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

New research to explore how socio-economic factors, other health concerns affect cancer treatment

Fighting colorectal cancer

GHIT Fund invests in phase 3 clinical trial for pediatric formulation of ‘snail fever’ drug

Researchers develop biomaterials from apple waste for regeneration of bone, cartilage tissues

Novel Research Grants bring new insight to complexities of lupus

New imaging tool that spots lung infections could help prevent antibiotic overuse

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News